positions available now

Tag Archives: Reimbursement

PHARMAC prepares to take over the procurement of medical devices

Access to medical devices in New Zealand is changing   The Therapeutic Products Bill will be published shortly, resulting in PHARMAC assuming responsibility for the procurement and funding of medical devices in addition to their current brief of medicines. This … Continue reading

Posted in Life Sciences Industry, Market Access, Medical Device | Tagged , , , , , , | Comments Off on PHARMAC prepares to take over the procurement of medical devices

Defining value in the MBS Review

In May 2015 the Federal Government announced a review of the Medicare Benefits Schedule (MBS) with a view to bringing the MBS up-to-date and increase the value derived from the more than 5,700 listed items. The announcement of this review … Continue reading

Posted in Market Access, MBS, Medicare Benefits Schedule, MSAC, PBAC, PBS | Tagged , , , , , , | Comments Off on Defining value in the MBS Review

Medicines don’t add value if they stay on the shelf

Medicines don’t provide the value they were designed to deliver if they’re not made available and aren’t within financial reach of patients. Medicines don’t add value if they stay on the shelf. Yet the tension between the increasingly high cost … Continue reading

Posted in Commercial Eyes, Life Sciences Industry | Tagged , | Comments Off on Medicines don’t add value if they stay on the shelf

Commercial Eyes Recruiting: Market Access Manager

Growth and structural change within the Market Access team at Commercial Eyes means that we are now seeking a full time Market Access Manager.The successful applicant will be second in charge to the Director of the Market Access team and … Continue reading

Posted in Commercial Eyes, Life Sciences Industry, Market Access | Tagged , , | Comments Off on Commercial Eyes Recruiting: Market Access Manager

Uncertain, unknown or essentially unknowable?

‘Understanding what is uncertain, what is unknown or what is essentially unknowable, and what to do about it in a reimbursement submission’ – this was the key topic for discussion of the Australian Chapter of the International Society for Pharmacoeconomics … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , | Comments Off on Uncertain, unknown or essentially unknowable?

Disinvestment in health care: friend or foe?

The clinical trial that led Commercial Eyes Market Access Consultant, Bridie Murphy, into the world of health technology assessment is still in the spotlight five years on. In July, The Conversation featured an article that looked at this and other … Continue reading

Posted in Clinical Development, Commercial Eyes, Life Sciences Industry, Market Access, MSAC | Tagged , , , | Comments Off on Disinvestment in health care: friend or foe?

A Manager’s New Mindset

Andrew Manton is Commercial Eyes’ new Manager, Reimbursement and Pricing. He talks to Eye Spy about what drew him to consulting, what he brings to CEPL, and how the company is well placed to deal with industry’s changing needs. Continue reading

Posted in Commercial Eyes, Market Access | Tagged , | Comments Off on A Manager’s New Mindset

Whim Decisions Reimbursed

Commercial Eyes reimbursement consultant Janet Wilson says a snap decision literally broadened her horizons. Continue reading

Posted in Commercial Eyes | Tagged | Comments Off on Whim Decisions Reimbursed
Copyright © 2014 Commercial Eyes